News

Going to college has consistently conferred a large wage premium. We show that the relative premium received by lower-income Americans has halved since 1960. We decompose this steady rise in ...
LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell ...
LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its ...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ...
Ratings for Arcutis Biotherapeutics ARQT were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced a $38 million Series D-2 financing. For ...
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Iovance Biotherapeutics. The Motley Fool has a disclosure policy.
Burgum said he was encouraged by Hochul’s “willingness to move forward on critical pipeline capacity.” “Americans who live in New York and New England would see significant economic ...
House Republicans removed two contentious provisions from their party-line megabill bill Monday that would have allowed pipeline developers to pay for accelerated permitting. The budget ...
That is why they have been fighting for over a decade to remove the Line 5 pipeline not only from land they own but also from proximity to the life-giving watershed. Line 5, owned by Calgary-based ...